GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation
- Written by Newsfile
New York, New York--(Newsfile Corp. - April 15, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the...